TRICREST

Title: A phase II, single arm, multicentre trial of triamcinolone with a GnRH analog for castration resistant prostate cancer
Disease site: Prostate cancer
Status: Follow up

Trial Design: A single arm, multi-centre phase II trial of intra-muscular (IM) triamcinolone with a GnRH analog for castration resistant prostate cancer (CRPC).

Trial details

Chief Investigator: Dr J. Shamash
Trial contact: bci-tricrest@qmul.ac.uk
EudraCT: 2010-022010-32
Sponsor: Barts Health NHS Trust
Participating countries: UK

Patient friendly information

Cancer Research UK website A trial of triamcinolone with hormone therapy for prostate cancer (TRICREST)

Clinical Trial Portfolio

Click here to to see a list of our clinical trials that are currently in set up or those that are open to recruitment.